Morgan Stanley »

Viracta Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Viracta Therapeutics (VIRX) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Viracta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viracta Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viracta Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2023-09-30 $63k 60k 1.04
2023-06-30 $83k 59k 1.41
2022-12-31 $62k 62k 1.00
2022-06-30 $403k 88k 4.57
2022-03-31 $325k 68k 4.80
2021-06-30 $0 36k 0.00